A Study of AMDX-2011P in Participants With CAA

NCT05709314 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Cerebral Amyloid Angiopathy

Interventions

DRUG: AMDX-2011P

Sponsor

Amydis Inc.